These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3019970)

  • 1. Toxicity and biodistribution of the radioprotectors, WR2721, WR77913, and WR3689, in the CNS following intraventricular or intracisternal administration.
    Spence AM; Edmondson SW; Krohn KA; Grunbaum Z; Rasey JS; Steele JE
    Int J Radiat Oncol Biol Phys; 1986 Sep; 12(9):1653-60. PubMed ID: 3019970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of the radioprotective drug 35S-labeled 3-amino-2-hydroxypropyl phosphorothioate (WR77913).
    Rasey JS; Grunbaum Z; Krohn KA; Menard TW; Spence AM
    Radiat Res; 1985 Apr; 102(1):130-7. PubMed ID: 2984715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of aminoalkylphosphorothioate radioprotective drugs to rodent tissue proteins.
    Livesey JC; Grunbaum Z; Krohn KA
    Biochem Pharmacol; 1990 Jun; 39(11):1807-12. PubMed ID: 2160821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: comparison with prior results with phosphorothioates.
    Spence AM; Rasey JS; Dwyer-Hansen L; Grunbaum Z; Livesey J; Chin L; Nelson N; Stein D; Krohn KA; Ali-Osman F
    Radiother Oncol; 1995 Jun; 35(3):216-26. PubMed ID: 7480825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioprotection in rat spinal cord with WR-2721 following cerebral lateral intraventricular injection.
    Spence AM; Krohn KA; Edmondson SW; Steele JE; Rasey JS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1479-82. PubMed ID: 3019963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of WR-2721 on fetal development in the rat.
    Sodicoff M; Ziskin MC; Conger AD
    Radiat Res; 1986 Jul; 107(1):49-57. PubMed ID: 3016791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of WR-2721 administered in single and multiple doses.
    Kligerman MM; Glover DJ; Turrisi AT; Norfleet AL; Yuhas JM; Coia LR; Simone C; Glick JH; Goodman RL
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1773-6. PubMed ID: 6090369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
    Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of WR-2721 toxicity and radioprotection by an inhibitor of alkaline phosphatase.
    Brown DQ; Shaw LM; Pittock JW; Mann DJ; Hardiman J; Pogach R; Gold J
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1491-3. PubMed ID: 3019966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The differential protection by WR2721 of skin versus growing cartilage following irradiation in weanling rats.
    Constine LS; Rubin P; Gregory P
    Radiat Res; 1987 Apr; 110(1):61-71. PubMed ID: 3031722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of radioprotector WR2721.
    Cairnie AB
    Radiat Res; 1983 Apr; 94(1):221-6. PubMed ID: 6304804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute toxicity and radioprotective effectiveness of gammaphos on intramuscular administration to mice].
    Kuna P
    Radiobiologiia; 1985; 25(1):59-62. PubMed ID: 2983365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of radioprotective agents on X-ray cataracts.
    Reddy VN; Ikebe H; Giblin FJ; Clark JI; Livesey JC
    Lens Eye Toxic Res; 1989; 6(4):573-88. PubMed ID: 2562120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of the phosphorothioate radioprotectors WR-2721 and WR-3689.
    Livesey JC; Rasey JS; Vertrees S; Freeman LM; Magee S; Nelson NJ; Chin L; Grunbaum Z; Krohn KA
    Pharmacol Ther; 1988; 39(1-3):215-7. PubMed ID: 2849127
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioprotectors as late preventive agents against carbon tetrachloride induced liver necrosis: protection by 2-(3-aminopropylamino) ethylphosphorothioic acid (WR2721).
    Valles EG; de Castro CR; Castro JA
    Exp Mol Pathol; 1995 Oct; 63(2):101-9. PubMed ID: 8941044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine.
    Schor NF
    Biochem Pharmacol; 1988 May; 37(9):1751-62. PubMed ID: 2897858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I clinical studies with WR-2721.
    Kligerman MM; Shaw MT; Slavik M; Yuhas JM
    Cancer Clin Trials; 1980; 3(3):217-21. PubMed ID: 6254682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition for polyamine uptake into rat lung slices by WR2721 and analogues.
    Wyatt I; Moore RB; Smith LL
    Int J Radiat Biol; 1989 Mar; 55(3):463-72. PubMed ID: 2564041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.